Hutchinson-Gilford Syndrome Completed Phase 2 Trials for Zoledronic acid (DB00399)

IndicationStatusPhase
DBCOND0036510 (Hutchinson-Gilford Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00879034A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With ProgeriaTreatment